TERPS Trial for De Novo Oligometastic Prostate Cancer
Recruiting
This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: UC San Diego Moores Cancer Center, La Jolla, California +8 locations
Conditions: Prostate Cancer, Oligometastatic Disease
TmCD19-IL18 in CD19+ Cancers
Recruiting
This is a Phase I, open-label dose finding study to assess the safety, tolerability, manufacturing feasibility, pharmacokinetics, and preliminary efficacy of TmCD19-IL18 CAR T cells in patients with CD19+ cancers. This study will take place in two parts: a Dose-Finding Phase to determine the maximum tolerate dose (MTD), followed by a Dose Expansion Phase. In the Dose-Finding Phase, up to 4 total dose levels will be evaluated using a 3+3 dose escalation design in order to determine the MTD (as de... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Non Hodgkin Lymphoma
Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants
Recruiting
The purpose of the present study is to examine the pharmacokinetics and pharmacodynamics of cannabigerol (CBG; CHI-914), a naturally occurring chemical constituent of the cannabis plant formulated for oral consumption, in healthy adults. The study will utilize a within-subjects, placebo-controlled, double-blind, ascending-dose design.Upon enrollment, participants will complete 5 oral dosing conditions (placebo, 25, 50, 100, and 200 mg CBG). Each condition will consist of a single acute drug expo... Read More
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
09/23/2024
Locations: Behavioral Pharmacology Research Unit, Baltimore, Maryland
Conditions: Behavioral Pharmacology of Cannabis
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Recruiting
This is a single-site prospective study to describe efficacy endpoints of single agent memantine in patients with unresectable, locally advanced, or metastatic HCC otherwise not deemed candidates for intensive systemic therapy. In addition to the primary endpoint and multiple secondary efficacy endpoints, we will describe changes in quality of life on treatment over time.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: Inova Schar Cancer Institute, Fairfax, Virginia +1 locations
Conditions: Hepatocellular Carcinoma, Cirrhosis
Memory Training and Neural Plasticity
Recruiting
This study will evaluate the efficacy of working memory training in older adults with amnestic mild cognitive impairment (MCI).
Gender:
ALL
Ages:
60 years and above
Trial Updated:
09/23/2024
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Mild Cognitive Impairment
Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
Recruiting
A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair.
Gender:
FEMALE
Ages:
Between 18 years and 70 years
Trial Updated:
09/23/2024
Locations: Integrative Skin Science and Research, Sacramento, California
Conditions: Hair Thinning
Intermediate Visual Space Perception
Recruiting
The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perception involved in judging distance, the focus of this project, in the planning and/or execution of self-motion in the natural 3D environment. The theoretical knowledge to be gained from this project will... Read More
Gender:
ALL
Ages:
Between 18 years and 40 years
Trial Updated:
09/23/2024
Locations: University of Louisville, Louisville, Kentucky
Conditions: Vision
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Recruiting
This research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that targets plasma cells that make antibodies) and whether it can lower donor specific antibodies (DSA) levels to low enough levels to permit patients to proceed with allogeneic peripheral blood transplant (alloBMT). Those being asked to participate have high DSA levels that puts those being asked to participate at high risk of rejecting the avai... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Conditions: Hematologic Malignancy, Bone Marrow Transplant Rejection, Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Acute Lymphoblastic Leukemia (ALL), Adult, Multiple Myeloma, Aplastic Anemia, Lymphoma, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Myeloid Leukemia, Myelofibrosis
Hirschsprung Disease Genetic Study
Recruiting
Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
Gender:
ALL
Ages:
Between 1 week and 100 years
Trial Updated:
09/23/2024
Locations: New York University School of Medicine, New York, New York
Conditions: Hirschsprung Disease
Characterizing In Vivo Oral Lesion Impedances
Recruiting
The primary objective of this study is to demonstrate a significant difference in electrical impedance between normal, benign, premalignant, and malignant oral lesions using a custom device. The secondary study objective is to create a database of in vivo electrical impedance spectra and images of oral lesions. This will be achieved by collecting Electrical Impedance sensing data and images from two cohorts of patients: Cohort I will consist of 200 patients undergoing oral lesion biopsies and Co... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Conditions: Oral Lesion
Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
Recruiting
The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in the Pedaling for Parkinson's (PFP) community-based exercise program. Participants will exercise at community-based sites 3x/week for 12 months. All participants will undergo genotyping using an array th... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/23/2024
Locations: The Cleveland Clinic, Cleveland, Ohio
Conditions: Parkinson Disease
Randomized Controlled Trial for Ankle Fracture Pain Control
Recruiting
This project is a multicenter, three armed, prospective randomized control trial studying the effectiveness of a long-acting local anesthetic "cocktail" in patients undergoing operative fixation of ankle fractures.
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
09/23/2024
Locations: Lahey Hospital & Medical Center, Burlington, Massachusetts
Conditions: Ankle Fractures